A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.
A medication that has long been used to treat high blood pressure could also help make an important class of cancer drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results